Reported by New York Post •
14 Public broadcaster provisional
Why this rating? · 1 signal

Signals flagged in the original

  • loaded language: 'destroys'

Provisional estimate — refines shortly Full breakdown ↓

3-year-old boy declared cancer-free after CAR T-cell therapy

A 3-year-old boy with hepatoblastoma was declared cancer-free after receiving two doses of an experimental CAR T-cell therapy. This treatment, which modifies T cells to target cancer cells, showed promising results, indicating complete regression of the disease after one year. The findings were published in The New England Journal of Medicine and highlight the potential of CAR T-cell therapy for treating solid tumors.

People
Andras Heczey

Our neutral summary

A 3-year-old boy with hepatoblastoma was declared cancer-free after receiving two doses of an experimental CAR T-cell therapy. This treatment, which modifies T cells to target cancer cells, showed promising results, indicating complete regression of the disease after one year. The findings were published in The New England Journal of Medicine and highlight the potential of CAR T-cell therapy for treating solid tumors.

Read the full story at New York Post

The reporting belongs to New York Post; we don't reproduce it.

Annotating as

No note attached

on this article.

Language Analysis

Loaded-language score 14/100
wirepublicmainstream flavoredpartisanadvocacy
Inflammatory language 3/100
Sentiment +50/100

Loaded Language Removed

  • ✕ loaded language: 'destroys'

Original vs. Neutral

Original Headline

3-year-old boy’s quick-spreading cancer is cured thanks to 2 doses of new treatment

Neutral Headline

3-year-old boy declared cancer-free after CAR T-cell therapy